 Laura Fenton
Concepts (342)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Stem Neoplasms | 5 | 2015 | 88 | 0.940 |
Why?
| | Tomography, X-Ray Computed | 11 | 2014 | 2438 | 0.870 |
Why?
| | Scrotum | 2 | 2016 | 24 | 0.830 |
Why?
| | Magnetic Resonance Imaging | 19 | 2019 | 3272 | 0.830 |
Why?
| | Neuroimaging | 1 | 2022 | 238 | 0.790 |
Why?
| | Brain | 6 | 2022 | 2793 | 0.670 |
Why?
| | Ganglioglioma | 2 | 2015 | 34 | 0.660 |
Why?
| | Esophagus | 3 | 2015 | 237 | 0.640 |
Why?
| | Wounds, Nonpenetrating | 3 | 2016 | 286 | 0.630 |
Why?
| | Eosinophilic Esophagitis | 2 | 2020 | 271 | 0.600 |
Why?
| | Diagnostic Techniques, Digestive System | 1 | 2015 | 10 | 0.590 |
Why?
| | Esophageal Stenosis | 1 | 2015 | 49 | 0.560 |
Why?
| | Brain Diseases | 2 | 2019 | 155 | 0.550 |
Why?
| | Infratentorial Neoplasms | 1 | 2014 | 36 | 0.520 |
Why?
| | Osteitis | 1 | 2013 | 4 | 0.500 |
Why?
| | Eosinophils | 1 | 2015 | 276 | 0.500 |
Why?
| | Glioma | 2 | 2009 | 301 | 0.480 |
Why?
| | Child | 32 | 2022 | 18852 | 0.470 |
Why?
| | Child, Preschool | 24 | 2019 | 9898 | 0.470 |
Why?
| | Liver Neoplasms | 3 | 2008 | 467 | 0.460 |
Why?
| | Gastritis | 1 | 2013 | 75 | 0.460 |
Why?
| | Prosthesis-Related Infections | 1 | 2013 | 73 | 0.450 |
Why?
| | Positron-Emission Tomography | 2 | 2019 | 309 | 0.450 |
Why?
| | Enteritis | 1 | 2013 | 72 | 0.450 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2014 | 207 | 0.450 |
Why?
| | Urea Cycle Disorders, Inborn | 1 | 2011 | 21 | 0.440 |
Why?
| | Ultrasonography | 3 | 2016 | 812 | 0.440 |
Why?
| | Eosinophilia | 1 | 2013 | 180 | 0.410 |
Why?
| | Infant | 21 | 2019 | 8399 | 0.410 |
Why?
| | Radiography | 8 | 2016 | 862 | 0.410 |
Why?
| | Colitis | 1 | 2013 | 215 | 0.400 |
Why?
| | Radiation Injuries | 2 | 2019 | 139 | 0.390 |
Why?
| | Spinal Fusion | 1 | 2013 | 219 | 0.390 |
Why?
| | Nervous System Diseases | 1 | 2011 | 254 | 0.350 |
Why?
| | Diagnosis, Differential | 8 | 2013 | 1433 | 0.330 |
Why?
| | Pamphlets | 1 | 2007 | 27 | 0.330 |
Why?
| | Male | 41 | 2019 | 61818 | 0.330 |
Why?
| | Astrocytoma | 2 | 2007 | 111 | 0.320 |
Why?
| | Adolescent | 24 | 2019 | 19218 | 0.320 |
Why?
| | Mutation | 3 | 2014 | 3480 | 0.310 |
Why?
| | Sensitivity and Specificity | 4 | 2013 | 1942 | 0.310 |
Why?
| | Deglutition Disorders | 2 | 2020 | 132 | 0.310 |
Why?
| | Infant, Newborn | 16 | 2019 | 5227 | 0.310 |
Why?
| | Female | 44 | 2019 | 64501 | 0.300 |
Why?
| | Humans | 57 | 2022 | 119430 | 0.300 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2008 | 196 | 0.300 |
Why?
| | Radiation Dosage | 1 | 2007 | 151 | 0.300 |
Why?
| | Brain Neoplasms | 3 | 2012 | 1001 | 0.300 |
Why?
| | Stroke | 3 | 2022 | 1005 | 0.290 |
Why?
| | Reproducibility of Results | 6 | 2015 | 2982 | 0.290 |
Why?
| | Vertebral Artery Dissection | 2 | 2022 | 19 | 0.280 |
Why?
| | Retrospective Studies | 13 | 2022 | 12359 | 0.260 |
Why?
| | Venous Thrombosis | 2 | 2016 | 137 | 0.260 |
Why?
| | Tomography, Emission-Computed | 1 | 2003 | 91 | 0.240 |
Why?
| | Encephalocele | 1 | 2022 | 7 | 0.240 |
Why?
| | Testicular Hydrocele | 1 | 2002 | 2 | 0.240 |
Why?
| | Neuroblastoma | 2 | 2010 | 133 | 0.240 |
Why?
| | Brain Stem | 1 | 2003 | 112 | 0.230 |
Why?
| | Rhabdoid Tumor | 1 | 2003 | 76 | 0.230 |
Why?
| | Teratoma | 1 | 2003 | 92 | 0.230 |
Why?
| | Neurofibroma, Plexiform | 1 | 2001 | 2 | 0.220 |
Why?
| | Cerebral Cortex | 2 | 2019 | 517 | 0.220 |
Why?
| | Diagnostic Errors | 1 | 2003 | 161 | 0.220 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2001 | 26 | 0.220 |
Why?
| | Abdomen | 1 | 2002 | 127 | 0.220 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 87 | 0.220 |
Why?
| | Mesentery | 1 | 2001 | 78 | 0.210 |
Why?
| | Peritoneal Neoplasms | 1 | 2001 | 56 | 0.210 |
Why?
| | Parietal Bone | 1 | 2000 | 10 | 0.210 |
Why?
| | Child Abuse | 2 | 2012 | 540 | 0.210 |
Why?
| | Skull Fractures | 1 | 2000 | 23 | 0.210 |
Why?
| | Connective Tissue | 1 | 2000 | 45 | 0.210 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2000 | 18 | 0.200 |
Why?
| | Vitelline Duct | 1 | 2000 | 1 | 0.200 |
Why?
| | Intracranial Hemorrhages | 1 | 2000 | 75 | 0.200 |
Why?
| | Intestinal Obstruction | 1 | 2000 | 39 | 0.190 |
Why?
| | Radiotherapy | 2 | 2019 | 197 | 0.190 |
Why?
| | Prognosis | 5 | 2014 | 3587 | 0.190 |
Why?
| | Parents | 1 | 2007 | 1196 | 0.190 |
Why?
| | Bevacizumab | 1 | 2019 | 125 | 0.180 |
Why?
| | Corpus Callosum | 1 | 2019 | 57 | 0.180 |
Why?
| | Intestine, Small | 1 | 2000 | 147 | 0.180 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2019 | 47 | 0.180 |
Why?
| | tau Proteins | 1 | 2019 | 69 | 0.180 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2007 | 1263 | 0.170 |
Why?
| | Esophagoscopy | 2 | 2020 | 191 | 0.170 |
Why?
| | Aneurysm, Dissecting | 1 | 2019 | 110 | 0.170 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2013 | 134 | 0.170 |
Why?
| | Disease-Free Survival | 2 | 2014 | 692 | 0.170 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2003 | 1429 | 0.170 |
Why?
| | Central Nervous System Neoplasms | 1 | 2019 | 127 | 0.170 |
Why?
| | Fatty Liver | 2 | 2012 | 281 | 0.170 |
Why?
| | Fatal Outcome | 4 | 2016 | 313 | 0.170 |
Why?
| | Smith-Magenis Syndrome | 1 | 2017 | 2 | 0.170 |
Why?
| | Angiogenesis Inhibitors | 1 | 2019 | 221 | 0.160 |
Why?
| | Moyamoya Disease | 1 | 2017 | 12 | 0.160 |
Why?
| | Radiopharmaceuticals | 2 | 2013 | 203 | 0.160 |
Why?
| | Magnetic Resonance Angiography | 1 | 2019 | 242 | 0.160 |
Why?
| | Young Adult | 6 | 2015 | 11188 | 0.160 |
Why?
| | White Matter | 1 | 2019 | 108 | 0.160 |
Why?
| | Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2016 | 7 | 0.160 |
Why?
| | Treatment Outcome | 8 | 2014 | 9525 | 0.160 |
Why?
| | Multimodal Imaging | 2 | 2019 | 103 | 0.160 |
Why?
| | Hyperammonemia | 1 | 2016 | 16 | 0.160 |
Why?
| | Bronchopulmonary Sequestration | 1 | 1996 | 12 | 0.160 |
Why?
| | Leigh Disease | 2 | 2013 | 17 | 0.150 |
Why?
| | Intracranial Thrombosis | 1 | 2016 | 17 | 0.150 |
Why?
| | Stomach | 1 | 1996 | 95 | 0.150 |
Why?
| | Brain Infarction | 1 | 2016 | 22 | 0.150 |
Why?
| | Cerebral Veins | 1 | 2016 | 13 | 0.150 |
Why?
| | Vascular Malformations | 1 | 2016 | 42 | 0.150 |
Why?
| | Portal Vein | 1 | 2016 | 93 | 0.150 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 19 | 0.150 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2015 | 9 | 0.150 |
Why?
| | Adrenal Gland Neoplasms | 1 | 1996 | 80 | 0.150 |
Why?
| | Neurosurgical Procedures | 1 | 2017 | 147 | 0.140 |
Why?
| | DNA Mutational Analysis | 2 | 2014 | 407 | 0.140 |
Why?
| | Cerebral Infarction | 1 | 2015 | 49 | 0.140 |
Why?
| | Fibrin Fibrinogen Degradation Products | 2 | 2012 | 80 | 0.140 |
Why?
| | Abdominal Pain | 2 | 2011 | 137 | 0.140 |
Why?
| | Contrast Media | 3 | 2019 | 430 | 0.140 |
Why?
| | Carotid Stenosis | 1 | 2015 | 54 | 0.140 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.140 |
Why?
| | Temporal Lobe | 1 | 2015 | 102 | 0.140 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.140 |
Why?
| | Spasm | 1 | 2013 | 16 | 0.130 |
Why?
| | Alzheimer Disease | 1 | 2019 | 472 | 0.120 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2012 | 5 | 0.120 |
Why?
| | Cerebral Arterial Diseases | 1 | 2012 | 42 | 0.120 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2012 | 13 | 0.120 |
Why?
| | Pons | 1 | 2012 | 34 | 0.120 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2012 | 85 | 0.110 |
Why?
| | DNA, Mitochondrial | 1 | 2013 | 186 | 0.110 |
Why?
| | Athletic Injuries | 2 | 2016 | 468 | 0.110 |
Why?
| | Accidents | 1 | 2012 | 42 | 0.110 |
Why?
| | Splenomegaly | 1 | 2011 | 16 | 0.110 |
Why?
| | Craniotomy | 1 | 2012 | 66 | 0.110 |
Why?
| | Hemoglobin SC Disease | 1 | 2011 | 13 | 0.110 |
Why?
| | Necrosis | 3 | 2019 | 234 | 0.110 |
Why?
| | Decompression, Surgical | 1 | 2012 | 97 | 0.110 |
Why?
| | Succinate-CoA Ligases | 1 | 2010 | 4 | 0.100 |
Why?
| | Brain Diseases, Metabolic | 1 | 2010 | 7 | 0.100 |
Why?
| | Anticoagulants | 1 | 2015 | 549 | 0.100 |
Why?
| | Liver Diseases | 2 | 2010 | 288 | 0.100 |
Why?
| | Scoliosis | 1 | 2013 | 184 | 0.100 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 547 | 0.100 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2010 | 76 | 0.100 |
Why?
| | Recurrence | 3 | 2022 | 1013 | 0.100 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 248 | 0.100 |
Why?
| | Mitochondrial Diseases | 1 | 2010 | 68 | 0.100 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 253 | 0.090 |
Why?
| | Incidental Findings | 1 | 2010 | 85 | 0.090 |
Why?
| | Optic Neuritis | 1 | 2009 | 33 | 0.090 |
Why?
| | Thrombophilia | 1 | 2009 | 76 | 0.090 |
Why?
| | Cerebellar Neoplasms | 1 | 2010 | 121 | 0.090 |
Why?
| | Facial Injuries | 1 | 2009 | 18 | 0.090 |
Why?
| | Facial Bones | 1 | 2009 | 37 | 0.090 |
Why?
| | Lymphoproliferative Disorders | 1 | 2009 | 88 | 0.090 |
Why?
| | Autopsy | 2 | 2016 | 102 | 0.090 |
Why?
| | Medulloblastoma | 1 | 2010 | 167 | 0.090 |
Why?
| | Chromosomes, Human, Y | 1 | 2008 | 11 | 0.090 |
Why?
| | Diabetes, Gestational | 1 | 2012 | 289 | 0.090 |
Why?
| | Liver | 2 | 2016 | 1887 | 0.090 |
Why?
| | Chromosomes, Human, X | 1 | 2008 | 46 | 0.090 |
Why?
| | Prenatal Diagnosis | 1 | 2010 | 173 | 0.090 |
Why?
| | Sex Chromosome Aberrations | 1 | 2008 | 45 | 0.090 |
Why?
| | Craniopharyngioma | 1 | 2009 | 71 | 0.090 |
Why?
| | Aging | 1 | 2019 | 1740 | 0.090 |
Why?
| | Glioblastoma | 1 | 2010 | 257 | 0.080 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2009 | 111 | 0.080 |
Why?
| | Biopsy | 2 | 2010 | 1077 | 0.080 |
Why?
| | Aneuploidy | 1 | 2008 | 78 | 0.080 |
Why?
| | Meningomyelocele | 1 | 2008 | 60 | 0.080 |
Why?
| | Lung Diseases | 1 | 2014 | 736 | 0.080 |
Why?
| | Ultrasonography, Doppler | 1 | 2008 | 109 | 0.080 |
Why?
| | Obesity | 2 | 2012 | 2752 | 0.080 |
Why?
| | Adult | 8 | 2019 | 32835 | 0.080 |
Why?
| | Brain Injuries | 1 | 2012 | 491 | 0.080 |
Why?
| | Glucose Tolerance Test | 1 | 2008 | 372 | 0.080 |
Why?
| | Abnormalities, Multiple | 1 | 2008 | 177 | 0.080 |
Why?
| | Carotid Artery Thrombosis | 1 | 2005 | 6 | 0.070 |
Why?
| | Brain Ischemia | 1 | 2009 | 292 | 0.070 |
Why?
| | Mucormycosis | 1 | 2005 | 22 | 0.070 |
Why?
| | Vascular Diseases | 1 | 2009 | 241 | 0.070 |
Why?
| | Osteoporosis | 1 | 2008 | 209 | 0.070 |
Why?
| | Developmental Disabilities | 1 | 2008 | 252 | 0.070 |
Why?
| | Bone Density | 1 | 2008 | 427 | 0.070 |
Why?
| | Feasibility Studies | 2 | 2019 | 773 | 0.070 |
Why?
| | Metabolic Syndrome | 1 | 2008 | 397 | 0.060 |
Why?
| | Vincristine | 1 | 2003 | 104 | 0.060 |
Why?
| | Carboplatin | 1 | 2003 | 143 | 0.060 |
Why?
| | Sinusitis | 1 | 2005 | 171 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2016 | 4998 | 0.060 |
Why?
| | Hernia, Hiatal | 1 | 2003 | 28 | 0.060 |
Why?
| | Risk Factors | 5 | 2012 | 9298 | 0.060 |
Why?
| | Pilot Projects | 2 | 2019 | 1472 | 0.060 |
Why?
| | Pancreatic Neoplasms | 1 | 2010 | 750 | 0.060 |
Why?
| | Hemangioendothelioma | 1 | 2002 | 12 | 0.060 |
Why?
| | Vertebral Artery | 1 | 2022 | 28 | 0.060 |
Why?
| | Liver Transplantation | 1 | 2009 | 814 | 0.060 |
Why?
| | Ultrasonography, Prenatal | 2 | 2010 | 260 | 0.060 |
Why?
| | Spinal Cord Neoplasms | 1 | 2001 | 35 | 0.050 |
Why?
| | Neurofibromatosis 1 | 1 | 2001 | 32 | 0.050 |
Why?
| | Colorado | 4 | 2015 | 4583 | 0.050 |
Why?
| | Vitamin K Deficiency | 1 | 2000 | 11 | 0.050 |
Why?
| | Cross-Sectional Studies | 4 | 2019 | 4623 | 0.050 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2000 | 35 | 0.050 |
Why?
| | Dilatation | 1 | 2020 | 60 | 0.050 |
Why?
| | Enema | 1 | 2000 | 35 | 0.050 |
Why?
| | Herpes Simplex | 1 | 2000 | 95 | 0.050 |
Why?
| | Mental Disorders | 1 | 2008 | 979 | 0.050 |
Why?
| | Ependymoma | 1 | 2001 | 155 | 0.050 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 62 | 0.050 |
Why?
| | Neck | 1 | 2019 | 87 | 0.050 |
Why?
| | Carbolines | 1 | 2019 | 34 | 0.050 |
Why?
| | Diseases in Twins | 1 | 2000 | 252 | 0.050 |
Why?
| | Biomarkers | 1 | 2009 | 3593 | 0.050 |
Why?
| | Spectrum Analysis | 1 | 2019 | 91 | 0.040 |
Why?
| | Aniline Compounds | 1 | 2019 | 68 | 0.040 |
Why?
| | Atrophy | 1 | 2019 | 154 | 0.040 |
Why?
| | Pregnancy | 5 | 2012 | 5571 | 0.040 |
Why?
| | Thiazoles | 1 | 2019 | 119 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2564 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 2006 | 0.040 |
Why?
| | Cohort Studies | 3 | 2016 | 5159 | 0.040 |
Why?
| | Organ Size | 1 | 2019 | 504 | 0.040 |
Why?
| | Gastroepiploic Artery | 1 | 2017 | 4 | 0.040 |
Why?
| | Cerebral Revascularization | 1 | 2017 | 10 | 0.040 |
Why?
| | Dexamethasone | 1 | 2019 | 313 | 0.040 |
Why?
| | Phenotype | 2 | 2019 | 2939 | 0.040 |
Why?
| | Cerebral Angiography | 1 | 2017 | 97 | 0.040 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2016 | 35 | 0.040 |
Why?
| | Acidosis, Lactic | 1 | 2016 | 29 | 0.040 |
Why?
| | Congenital Abnormalities | 1 | 1996 | 72 | 0.040 |
Why?
| | Intellectual Disability | 1 | 2017 | 126 | 0.040 |
Why?
| | Florida | 1 | 2015 | 85 | 0.040 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 560 | 0.040 |
Why?
| | Endpoint Determination | 1 | 2015 | 69 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2015 | 290 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2019 | 563 | 0.030 |
Why?
| | Observer Variation | 1 | 2015 | 342 | 0.030 |
Why?
| | Combined Modality Therapy | 2 | 2009 | 1227 | 0.030 |
Why?
| | Hemorrhage | 2 | 2015 | 628 | 0.030 |
Why?
| | Molybdoferredoxin | 1 | 2012 | 10 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 307 | 0.030 |
Why?
| | Erythroblastosis, Fetal | 1 | 1972 | 4 | 0.030 |
Why?
| | Persistent Vegetative State | 1 | 2012 | 4 | 0.030 |
Why?
| | Quality Assurance, Health Care | 1 | 2015 | 383 | 0.030 |
Why?
| | Pedigree | 1 | 2013 | 477 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2737 | 0.030 |
Why?
| | Glasgow Coma Scale | 1 | 2012 | 158 | 0.030 |
Why?
| | Splenectomy | 1 | 2011 | 51 | 0.030 |
Why?
| | Middle Aged | 3 | 2019 | 29262 | 0.030 |
Why?
| | Time Factors | 2 | 2015 | 7096 | 0.030 |
Why?
| | Disabled Children | 1 | 2012 | 74 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2019 | 3335 | 0.030 |
Why?
| | Karyotyping | 1 | 2010 | 115 | 0.030 |
Why?
| | Accidents, Traffic | 1 | 2012 | 182 | 0.030 |
Why?
| | Anemia | 1 | 1972 | 168 | 0.030 |
Why?
| | Aged | 2 | 2019 | 20621 | 0.020 |
Why?
| | Factor VIII | 1 | 2009 | 48 | 0.020 |
Why?
| | Rare Diseases | 1 | 2010 | 85 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2010 | 201 | 0.020 |
Why?
| | Optic Nerve | 1 | 2009 | 68 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2005 | 3308 | 0.020 |
Why?
| | Research Design | 1 | 2015 | 988 | 0.020 |
Why?
| | Wheelchairs | 1 | 2008 | 18 | 0.020 |
Why?
| | Fractures, Spontaneous | 1 | 2008 | 16 | 0.020 |
Why?
| | Cesarean Section | 1 | 2010 | 164 | 0.020 |
Why?
| | Calcium, Dietary | 1 | 2008 | 55 | 0.020 |
Why?
| | Fetal Diseases | 1 | 2010 | 178 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2008 | 127 | 0.020 |
Why?
| | Gestational Age | 2 | 2010 | 790 | 0.020 |
Why?
| | Mobility Limitation | 1 | 2008 | 68 | 0.020 |
Why?
| | Pancreatectomy | 1 | 2010 | 164 | 0.020 |
Why?
| | Body Composition | 1 | 2012 | 773 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 482 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 781 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2010 | 338 | 0.020 |
Why?
| | Recovery of Function | 1 | 2012 | 616 | 0.020 |
Why?
| | Adiposity | 1 | 2012 | 511 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2009 | 358 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 258 | 0.020 |
Why?
| | Prenatal Care | 1 | 2010 | 255 | 0.020 |
Why?
| | Bleomycin | 1 | 2009 | 214 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 356 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2008 | 211 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 6916 | 0.020 |
Why?
| | Mucor | 1 | 2005 | 8 | 0.020 |
Why?
| | Cavernous Sinus | 1 | 2005 | 13 | 0.020 |
Why?
| | Telencephalon | 1 | 2005 | 18 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2269 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2010 | 2159 | 0.020 |
Why?
| | Survival Rate | 1 | 2010 | 1874 | 0.020 |
Why?
| | Orbit | 1 | 2005 | 41 | 0.020 |
Why?
| | Paranasal Sinuses | 1 | 2005 | 59 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1803 | 0.020 |
Why?
| | Triglycerides | 1 | 2008 | 557 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 3010 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2010 | 1214 | 0.020 |
Why?
| | Prospective Studies | 2 | 2009 | 6605 | 0.020 |
Why?
| | Cleft Lip | 1 | 2003 | 31 | 0.020 |
Why?
| | Incidence | 1 | 2009 | 2512 | 0.010 |
Why?
| | United States | 1 | 2019 | 12946 | 0.010 |
Why?
| | Cleft Palate | 1 | 2003 | 43 | 0.010 |
Why?
| | Estrogen Receptor Modulators | 1 | 2001 | 19 | 0.010 |
Why?
| | Laminectomy | 1 | 2001 | 28 | 0.010 |
Why?
| | Etoposide | 1 | 2001 | 161 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1754 | 0.010 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2001 | 196 | 0.010 |
Why?
| | Tamoxifen | 1 | 2001 | 207 | 0.010 |
Why?
| | Low Back Pain | 1 | 2001 | 89 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2001 | 342 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3258 | 0.010 |
Why?
| | Body Mass Index | 1 | 2008 | 2101 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1999 | 217 | 0.010 |
Why?
| | Blood Glucose | 1 | 2008 | 1957 | 0.010 |
Why?
| | Appendicitis | 1 | 1999 | 120 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2001 | 839 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 1009 | 0.010 |
Why?
| | Parathyroid Glands | 1 | 1975 | 8 | 0.010 |
Why?
| | Pregnancy in Diabetics | 1 | 1975 | 89 | 0.010 |
Why?
| | Infant, Newborn, Diseases | 1 | 1975 | 104 | 0.010 |
Why?
| | Kidney Cortex Necrosis | 1 | 1972 | 1 | 0.010 |
Why?
| | Splenic Rupture | 1 | 1972 | 6 | 0.010 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 1972 | 17 | 0.010 |
Why?
| | Hemoperitoneum | 1 | 1972 | 15 | 0.010 |
Why?
| | Brain Edema | 1 | 1972 | 66 | 0.010 |
Why?
| | Pancreatic Diseases | 1 | 1972 | 66 | 0.010 |
Why?
| | Pulmonary Edema | 1 | 1972 | 159 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1972 | 90 | 0.010 |
Why?
| | Spleen | 1 | 1972 | 538 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 1972 | 400 | 0.010 |
Why?
| | Emergency Service, Hospital | 1 | 1999 | 1865 | 0.010 |
Why?
| | Hypocalcemia | 1 | 1975 | 29 | 0.000 |
Why?
| | Blood | 1 | 1975 | 103 | 0.000 |
Why?
| | Magnesium | 1 | 1975 | 158 | 0.000 |
Why?
| | Umbilical Cord | 1 | 1975 | 86 | 0.000 |
Why?
| | Phosphorus | 1 | 1975 | 93 | 0.000 |
Why?
| | Parathyroid Hormone | 1 | 1975 | 116 | 0.000 |
Why?
| | Phosphates | 1 | 1975 | 182 | 0.000 |
Why?
| | Calcium | 1 | 1975 | 1235 | 0.000 |
Why?
|
|
Fenton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|